Agility Clinical, Inc. Report issue

For profit Phase 1 Phase 2
Founded: Carlsbad CA United States (2012)

Organization Overview

First Clinical Trial
2015
NCT02594254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Agility Clinical, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 2)

Dental Caries (Phase 2)

Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 6